Clinical Trials Browser

Phase 1 × Cyclin-Dependent Kinase Inhibitor p16 × 90 days × Clear all

NCT07222267 2026-06-03

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Phase 1 Recruiting

Breast Neoplasms